Jun Inoue

Research field (1)： Tumor biology

Research theme for competitive and other funds (11)：

2021 - 2024 Optimization of miRNA therapeutics for clinical application
2018 - 2021 Development of therapeutic strategy based on autophagy activity for cancer therapy
2018 - 2021 Development of therapeutic miRNAs targeting BET family protein BRD4 for cancer
2015 - 2020 Establishment of novel concept for cancer diagnostics and therapeutics based on the systematic comprehension of cellular context in cancer
2015 - 2018 Development of therapeutic strategy based on autophagy activity for cancer therapy

Show all

Papers (53)：

Jun Inoue, Johji Inazawa. Cancer-associated miRNAs and their therapeutic potential. Journal of human genetics. 2021. 66. 9. 937-945
Chang Liu, Yasuyuki Gen, Kousuke Tanimoto, Tomoki Muramatsu, Jun Inoue, Johji Inazawa. Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular Therapy - Nucleic Acids. 2021. 25. 83-92
Yasuyuki Gen, Tomoki Muramatsu, Jun Inoue, Johji Inazawa. miR-766-5p targets super-enhancers by downregulating CBP and BRD4. Cancer research. 2021
Akira Takemoto, Kousuke Tanimoto, Seiichi Mori, Jun Inoue, Naoto Fujiwara, Tetsuo Noda, Johji Inazawa. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma. Cancer Science. 2021. 112. 10. 4377-4392
Jun Inoue, Masahiro Kishikawa, Hitoshi Tsuda, Yasuaki Nakajima, Takahiro Asakage, Johji Inazawa. Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma. Cancer science. 2021. 112. 7. 2792-2802

ｍore...

MISC (89)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page